SynthesisContraception2019
Altered pharmacokinetics of combined oral contraceptives in obesity - multistudy assessment.
Synthesis in Contraception, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 17 citations in OpenAlex.
- Trial
- Contraception for Adolescents and Young Women with Type 2 Diabetes-Specific Considerations.Current diabetes reports · 2022Review
- Obesity and hormonal contraception: an overview and a clinician's practical guide.Eating and weight disorders : EWD · 2020Review
- Pharmacokinetics of Hormonal Contraception in Individuals with Obesity: a Review.Current obstetrics and gynecology reports · 2020Article
- Levonorgestrel emergency contraception and bodyweight: are current recommendations consistent with historic data?Journal of drug assessment · 2020Article
- Contraceptive Options Following Gestational Diabetes: Current Perspectives.Open access journal of contraception · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
Abstract
objectiveThe objective was to evaluate the pharmacokinetics (PKs) of levonorgestrel (LNG)-containing combined oral contraceptives (COCs) in obese women. STUDY
designWe pooled and reanalyzed data from 89 women with different body mass index (BMI) categories from four clinical studies. The LNG and ethinyl estradiol (EE) PKs were analyzed utilizing a zero-order absorption (K
resultsIncreasing of body habitus metrics is correlated with decreasing C
conclusionsThe primary effects of obesity on LNG and EE were a modest increase in CL and a marked increase in distribution parameters. We observed no obesity-related differences in trough LNG and EE concentrations. IMPLICATIONS: This population PK analysis demonstrated reduced systemic exposure to LNG/EE oral contraceptives in obese subjects (C
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.